Skip to main content

Jefferies Financial Group Inc. Value Stock - Dividend - Research Selection

Jefferies financial group

ISIN: US47233W1099 , WKN: A2JMVU

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Leucadia National Corporation operates as a diversified holding company that focuses on financial service businesses and investments in the Americas, Europe, and Asia. Its services include equities research, sales, and trading; financing, securities lending, and other brokerage; wealth management; fixed income sales and trading; futures; equity capital markets, debt capital markets, and financial advisory; and asset management services. The company also provides online foreign exchange trading, contract for difference trading, spread betting, and related services. In addition, it develops and owns residential and mixed-use real estate properties in California, New York, Florida, Virginia, South Carolina, and Maine; provides capital solutions, investment sales advisory, and mortgage servicing for multifamily and commercial properties; and purchases automobile installment contracts, as well as owns and manages a portfolio of leases on used Harley-Davidson motorcycles. Further, it processes and markets fresh and chilled boxed beef, ground beef, beef by-products, consumer-ready beef and pork, and wet blue leather; oil and gas properties in the Bakken Shale oil field in North Dakota and Montana, and the Denver-Julesburg Basin in Wyoming; owns and operates 28 automobile dealerships; offers fixed wireless broadband services in Italy; manufactures and markets plastic netting and wood products; and mines gold and silver ores. The company was formerly known as Talcott National Corp. and changed its name to Leucadia National Corporation in June 1980. Leucadia National Corporation was founded in 1968 and is headquartered in New York, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


BNP Paribas Downgrades Unilever PLC (UL) from Outperform to Neutral

2026-01-14
Unilever PLC (NYSE:UL) is among the 7 Best Beauty Stocks to Buy Right Now. On January 8, 2026, TheFly reported that BNP Paribas had downgraded Unilever PLC (NYSE:UL) from Outperform to Neutral with a price target of $71. The firm stated that valuations in the consumer staples area are anticipated to stay “cheap.” Separately, on […]

Jefferies Financial Group Inc. Announces Pricing of $1,500,000,000 5.500% Senior Notes Due 2036

2026-01-13
NEW YORK, January 13, 2026--Jefferies Financial Group Inc. (NYSE: JEF) ("JFG", "we" or "our") today announced the pricing of its public offering of $1.5 billion aggregate principal amount of 5.500% Senior Notes due 2036 (the "Notes") with an effective yield of 5.605%, maturing February 15, 2036. The offering is expected to settle on January 16, 2026, subject to the satisfaction of customary closing conditions.

How Jefferies' Mixed Q4, Dividend Commitment and New Debt Issuance At Jefferies Financial Group (JEF) Has Changed Its Investment Story

2026-01-13
Jefferies Financial Group recently reported fourth-quarter 2025 results showing higher revenue of US$2,068.85 million but lower net income of US$215.04 million year-on-year, while its board affirmed a US$0.40 quarterly dividend payable in February 2026 and confirmed completion of a large multi-year share repurchase program. Alongside these earnings and capital return moves, Jefferies also issued new long-dated senior unsecured notes with fixed coupons of 5.00%, 6.00% and 6.25%, reshaping how...

How Collagen JV, Tax Credit Monetization and Jefferies Support Will Impact Darling Ingredients (DAR) Investors

2026-01-13
Recently, Jefferies reaffirmed its positive stance on Darling Ingredients, pointing to solid performance in the Feed segment and Diamond Green Diesel operations, alongside fresh corporate developments. At the same time, Darling Ingredients moved to deepen its presence in collagen and gelatin through a new Tessenderlo joint venture and monetized US$50,000,000 in production tax credits. Next, we’ll assess how the Tessenderlo collagen and gelatin joint venture could reshape Darling Ingredients’...

Jefferies Sees Amazon (AMZN) Well-Positioned for AI Inference and Production Workloads

2026-01-12
Amazon Inc. (NASDAQ:AMZN) is among the best software infrastructure stocks to buy according to hedge funds. On January 5, Jefferies hiked the stock price target from $275 to $300 and reiterated its Buy rating. The firm acknowledged that Amazon’s shares have underperformed in 2025, partly due to negative investor sentiment stemming from a perceived lag in […]

Jefferies Sees Alphabet’s (GOOGL) Data Moat and Cloud Growth Driving Long-Term Upside

2026-01-12
Alphabet Inc. (NASDAQ:GOOGL) is among the best software infrastructure stocks to buy according to hedge funds. On January 5, Jefferies reaffirmed its Buy rating but raised its price target on the stock from $320 to $365. As per the update, there were a number of factors that bolstered Jefferies’ positive case, and the first one among […]

Why Moderna Stock Is Dropping After Good News

2026-01-12
Moderna offered investors a glimpse at its upcoming earnings report as it pre-announced revenue above the midpoint of its prior guidance range. Presenting at the annual J.P. Morgan Healthcare Conference on Monday, Moderna said it expects 2025 revenue of roughly $1.9 billion, $100 million above the midpoint of the range communicated on the company’s third-quarter earnings call. The company still expects revenue growth of up to 10% in 2026, and reiterated that it expects non-adjusted operating expenses to decline to $4.9 billion from a range of $5 billion to $5.2 billion in 2025.

Jefferies’ $400 Oracle (ORCL) Target Reflects Confidence in AI Infrastructure

2026-01-12
Oracle Corporation (NYSE:ORCL) is among the best software infrastructure stocks to buy according to hedge funds. On January 5, Jefferies reaffirmed its Buy rating and $400 price target on the stock and named it one of its top picks, citing multiple factors, including its long-term positioning in the AI infrastructure space. While there have been concerns […]

Jefferies Cautious on Adobe (ADBE) As It Updates Outlook on Software Sector

2026-01-12
Adobe Inc. (NASDAQ:ADBE) is one of the most undervalued blue chip stocks to buy now. On January 5, 2026, TheFly reported that Jefferies downgraded Adobe Inc. (NASDAQ:ADBE) from ‘Buy’ to ‘Hold’, while reducing its price target from $500 to $400. The update comes as part of the firm’s 2026 software sector “playbook.” The firm sees increasing competitive […]

Medline’s $25 bln supply chain scale wins Jefferies “buy” in coverage debut

2026-01-12
Investing.com -- Jefferies initiated coverage of Medline Inc. (NASDAQ:MDLN) with a “buy” rating in a note dated Monday, citing the company’s combined supply chain and private-label product model and its scale in medical-surgical distribution.